m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00532
|
[1], [2], [3] | |||
: modification sites
Indirect
Enhancement
m6A modification
ID2
ID2
VIRMA
Methylation
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Protein virilizer homolog (VIRMA) | WRITER | |||
| m6A Target | DNA-binding protein inhibitor ID-2 (ID2) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> Adenosine-to-Inosine editing (A-to-I) | ||||
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | WRITER | View Details | ||
| Regulated Target | MicroRNA 19a (MIR19A) | View Details | |||
| Crosstalk Relationship | A-to-I → m6A | Enhancement | |||
| Crosstalk Mechanism | RNA modification indirectly impacts m6A modification through downstream signaling pathways | ||||
| Crosstalk Summary | ADAR1 interacts with MicroRNA 19a (MIR19A), increasing it's A-to-I level and promoting its physical interaction with DNA-binding protein inhibitor ID-2 (ID2), which was regulated by VIRMA-mediated m6A modification. | ||||
In-vitro Model |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
| Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | ||
| HN4 | Clear cell renal cell carcinoma | Homo sapiens | CVCL_IS30 | ||
| CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | ||
References
: modification sites
: m6A sites